Abstract
Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
https://doi.org/10.1016/j.ejca.2019.01.032
Copy DOIJournal: European Journal of Cancer | Publication Date: Mar 1, 2019 |
Histone deacetylase inhibitors valproic acid and vorinostat enhance trastuzumab-mediated antibody-dependent cell-mediated phagocytosis
Join us for a 30 min session where you can share your feedback and ask us any queries you have